©2024 Stanford Medicine
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Recruiting
I'm InterestedTrial ID: NCT04109846
Purpose
To determine how often embryos reported to be abnormal by preimplantation genetic testing
result in liveborn infants. To evaluate whether the pregnancies that result from these
embryos are higher risk for complications and whether the resulting babies have higher risk
for health or developmental issues in the first five years after birth.
Official Title
Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing
Stanford Investigator(s)
Ruth Lathi, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Eligibility
Inclusion Criteria:
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
Exclusion Criteria:
- Use of international donor eggs or sperm not tested according to FDA guidelines.
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
Intervention(s):
other: Non-euploid embryo transfer
other: Euploid Transfer
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alleigh Boyd, MS
408-688-9749